期刊文献+

降钙素原与社区获得性肺炎病情严重度评估 被引量:6

Role of procalcitonin in the evaluation of community - acquired pneumonia severity
下载PDF
导出
摘要 目的探讨社区获得性肺炎(CAP)病情严重度与降钙素原(PCT)的相关性,为CAP病情严重度的评估提供实验室依据。方法收集2008-10—2009-02期间我院收治的单纯CAP病例共38例,在入院24h、7d分别测定PCT、C-反应蛋白(CRP)、白细胞计数(WBC),应用肺炎病情严重度评分(PSI)评估病情。结果试验组入院24hPCT较健康对照组升高,差异有统计学意义(P〈0.01)。入院24h及7d:PCT均与PSI相关(r=0.539,r=0.472;P〈0.05);入院7dWBC与PSI相关(r=0.381,P〈0.05),CRP与PSI无相关性。结论与CRP、WBC相比,PCT能够更好反映CAP病情严重程度,可用于动态监测CAP病情。 Objective To discuss the correlation between procalcitonin(PCT), C - reactive protein (CRP), white blood cell count(WBC) and community-acquired pneumonia (CAP) severity. Methods Thirty - eight CAP patients without complications of COPD, bronchiectasia or other chronic lung diseases, and sixteen healthy controls were enrolled to the study. Serum PCT, CRP and WBC were measured and Pneumonia Severity Index (PSI) were calculated on the first day and the seventh day after their admission. Results The increase of PCT concentrations were obvious in CAP group (P〈0.01). On the first day, the correlation coefficient between PCT and PSI was significantly correlated ( r = 0.539, P 〈0.01), but there were no correlation between CRP and PSI(r=0.044,P 〉0.05),between WBC and PSI( r =-0.007 ,P 〉 0.05) respectively. On the seventh day, the correlation coefficient between CRP and PSI was non - correlated (r= 0.183,P 〉 0.05 ) , but between PCT and PSI ( r = 0.472 ,P 〈 0.05 ) , WBC and PSI( r = 0.381 ,P 〈0.05) were correlated respectively. Conclusion Serum PCT levels in CAP group were markedly elevated than that in control group. As a marker of pneumonia severity, PCT was superior to CRP and WBC.
出处 《中国急救医学》 CAS CSCD 北大核心 2009年第11期1026-1028,共3页 Chinese Journal of Critical Care Medicine
关键词 社区获得性肺炎(CAP) 降钙素原(PCT) C-反应蛋白(CRP) Community - acquired pneumonia Procalcitonin C - reactive protein
  • 相关文献

参考文献15

  • 1邓伟吾.社区获得性肺炎诊断治疗进展[J].中华结核和呼吸杂志,2004,27(1):10-12. 被引量:48
  • 2吴熙,于学忠.降钙素原[J].中国医学科学院学报,2008,30(2):231-235. 被引量:81
  • 3Tasabehji WR, Al - Quobaili FA, Al- Daher NA. Usefulness of procalcitonin and some inflammatory parameters in septic patients [ J ]. Saudi Med J,2008,29(4) :520 -525.
  • 4Arkader R, Troster E J, Lopes MR, et al. Procalcitonin does discriminate between sepsis and systemic inflammatory response syndrome [ J]. Arch Dis Child ,2006,91 (2) : 117 - 120.
  • 5社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3032
  • 6Fine M J, Auble TE, Yealy DM, et al. A prediction rule to identify low- risk patients with community- acquired pneumonia[ J]. N Engl J Med,1997,336(4) :243 -250.
  • 7Russwurm S, Wiederhold M, Oberhoffer M, et al. Procalcitonin as monocytic marker for early diagnosis in sep tic abortion [ J ]. Z Geburtsh Neonatol,2000,204( 1 ) :34 -38.
  • 8Carlet J. Rapid diagnostic methods in the detection of sepsis [ J ]. Infect Dis Clin North Am, 1999,13 ( 2 ) :483 - 494.
  • 9Gendrel D, Bohuon C. Procalcitonin as a marker of bacterial infection [ J ]. Pediar Infect Dis J ,2000,19 (8) :679 -687.
  • 10Sauer M, Tiede K, Fuchs D, et al. Procalcitonin, C - reactive protein, and endotoxin after bone marrow transplantation: identification of children at high risk of morbidity and mortality from sepsis[ J]. Bone Marrow Transplantation ,2003,31 ( 12 ) : 1137 - 1142.

二级参考文献66

  • 1沈定霞,罗燕萍,崔岩,赵莉萍,白立彦.分离产金属β-内酰胺酶的铜绿假单胞菌[J].中华医院感染学杂志,2004,14(1):86-88. 被引量:109
  • 2胡如雪.降钙素原(PCT)的临床应用价值[J].江西医学检验,2005,23(3):259-259. 被引量:39
  • 3刘又宁,陈民钧,赵铁梅,王辉,王睿,刘庆锋,蔡柏蔷,曹彬,孙铁英,胡云建,修清玉,周新,丁星,杨岚,卓建生,唐英春,张扣兴,梁德荣,吕晓菊,李胜歧,刘勇,俞云松,魏泽庆,应可净,赵峰,陈萍,侯晓娜.中国城市成人社区获得性肺炎665例病原学多中心调查[J].中华结核和呼吸杂志,2006,29(1):3-8. 被引量:784
  • 4Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153.
  • 5de Roux A,Marcos MA,Garcia E,et al.Viral community-acquired pneumonia in nonimmunocompromised adults.Chest,2004,125:1343-1351.
  • 6Ostrosky-Zeichner L,Alexander BD,Kett DH,et al.Multicenter clinical evaluation of the (1→3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.Clin Infect Dis,2005,41:654-659.
  • 7Food and Drug Administration,HHS.Class Ⅱ Special Controls Guidance Document:serological assays for the detection of betaglucan.Fed Reqist,2004,69:56934-56936.
  • 8Mandell LA,Marrie TJ,Grossman RF,et al.Canadian guidelines for the initial management of community-acquired pneumonia:an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society.The Canadian CommunityAcquired Pneumonia Working Group.Clin Infect Dis,2000,31:383-421.
  • 9Woodhead M,Blasi F,Ewig S,et al.Guidelines for the management of adult lower respiratory tract infections.Eur Respir J,2005,26:1138-1180.
  • 10Mandell LA,Bartlett JG,Dowell SF,et al.Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults.Clin Infect Dis,2003,37:1405-1433.

共引文献3141

同被引文献75

引证文献6

二级引证文献94

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部